# LIBTAYO

NDC: 61755-008
Generic name: cemiplimab-rwlc
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20180928

FDA application: BLA761097

## Active ingredients

- CEMIPLIMAB: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-008"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-008
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4347ae1f-d397-4f18-8b70-03897e1c054a